Relmada Therapeutics Inc.

(NASDAQ:RLMD) Trade

Symbol has changed to a new ticker symbol

(RLMDD)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Contact Information

Website: www.relmada.com
Email: straversa@relmada.com
Main Phone: +1 646 876-3459
Address: 880 Third Avenue
Address 2: 12th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10022

Issuer Information

Exchange: NGS
CEO: Sergio Traversa
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A